BE710872A - - Google Patents

Info

Publication number
BE710872A
BE710872A BE710872DA BE710872A BE 710872 A BE710872 A BE 710872A BE 710872D A BE710872D A BE 710872DA BE 710872 A BE710872 A BE 710872A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE710872A publication Critical patent/BE710872A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Drawers Of Furniture (AREA)
BE710872D 1967-02-17 1968-02-16 BE710872A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH238667A CH481110A (de) 1967-02-17 1967-02-17 Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
CH1167167A CH488705A (de) 1967-02-17 1967-08-18 Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates

Publications (1)

Publication Number Publication Date
BE710872A true BE710872A (cg-RX-API-DMAC10.html) 1968-08-16

Family

ID=25690322

Family Applications (1)

Application Number Title Priority Date Filing Date
BE710872D BE710872A (cg-RX-API-DMAC10.html) 1967-02-17 1968-02-16

Country Status (13)

Country Link
US (1) US3652543A (cg-RX-API-DMAC10.html)
AT (1) AT275533B (cg-RX-API-DMAC10.html)
BE (1) BE710872A (cg-RX-API-DMAC10.html)
CH (2) CH481110A (cg-RX-API-DMAC10.html)
DE (2) DE1695124A1 (cg-RX-API-DMAC10.html)
DK (1) DK115473B (cg-RX-API-DMAC10.html)
ES (1) ES350574A1 (cg-RX-API-DMAC10.html)
FR (2) FR1560654A (cg-RX-API-DMAC10.html)
GB (2) GB1221324A (cg-RX-API-DMAC10.html)
IL (1) IL29485A (cg-RX-API-DMAC10.html)
NL (1) NL6802257A (cg-RX-API-DMAC10.html)
NO (1) NO124369B (cg-RX-API-DMAC10.html)
SE (1) SE342043B (cg-RX-API-DMAC10.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT289812B (de) * 1968-08-09 1971-05-10 Geigy Ag J R Verfahren zur Herstellung des neuen 2-Methyl-7-chlor-2,3,4,5-tetrahydro-1H-3-benzazepins sowie seiner Säureadditionssalze
DE2016136A1 (de) * 1970-04-04 1971-10-14 C H Boehnnger Sohn, 6507 Ingel heim Neue 7 Acyl 1,2,4,5 tetrahydro (3H) 3 benzazepine
DE2143204C3 (de) * 1971-08-28 1979-09-27 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt N-Fluoralkyl-phenylisopropylamin-Derivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
DE2207430C3 (de) * 1972-02-14 1982-05-13 Pennwalt Corp., 19102 Philadelphia, Pa. 1,2,4,5-Tetrahydro-3H-3-benzazepin, ein Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Mittel
EP0080779B1 (en) * 1981-11-27 1986-07-16 Smithkline Beckman Corporation 3-benzazepines as alpha-2 antagonists
US4541954A (en) * 1984-09-05 1985-09-17 Smithkline Beckman Corporation Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
EP0254737B1 (en) * 1986-01-16 1990-07-25 Schering Corporation Fused benzazepines
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
US5015639A (en) * 1987-03-27 1991-05-14 Schering Corporation Substituted benzazepines, their preparation and pharmaceutical compositions containing them
AU617651B2 (en) * 1987-07-15 1991-12-05 Schering Corporation Fused benzazepines
FI923458A0 (fi) * 1990-02-02 1992-07-31 Schering Corp 4,5-cykloalkano-3-benzazepin-7-ol- derivat och deras anvaendning.
US6953787B2 (en) * 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
US20030220661A1 (en) * 2002-05-21 2003-11-27 Heartstent Corporation Transmyocardial implant delivery system
CN1805938B (zh) * 2003-06-17 2010-06-16 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
US8367657B2 (en) * 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
WO2005042490A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
WO2005042491A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
EP2149562A1 (en) 2004-12-21 2010-02-03 Arena Pharmaceuticals, Inc. method of preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate
NZ589951A (en) 2004-12-23 2012-11-30 Arena Pharm Inc 5HT2C receptor modulator compositions and methods of use
CA2646044A1 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
EP2099743B1 (en) * 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8822727B2 (en) * 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011071136A1 (ja) 2009-12-11 2011-06-16 アステラス製薬株式会社 線維筋痛症治療剤
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태
JP2013539470A (ja) 2010-09-01 2013-10-24 アリーナ ファーマシューティカルズ, インコーポレイテッド ロルカセリンと光学活性な酸との塩
EA201390335A1 (ru) 2010-09-01 2013-09-30 Арена Фармасьютикалз, Инк. Введение лоркасерина индивидуумам с почечной недостаточностью
KR20130101524A (ko) 2010-09-01 2013-09-13 아레나 파마슈티칼스, 인크. 5-ht2c 아고니스트의 비-흡습성 염
RU2674670C1 (ru) 2012-10-09 2018-12-12 Арена Фармасьютикалз, Инк. Способ коррекции массы тела

Also Published As

Publication number Publication date
ES350574A1 (es) 1969-11-16
GB1221324A (en) 1971-02-03
CH488705A (de) 1970-04-15
AT275533B (de) 1969-10-27
SE342043B (cg-RX-API-DMAC10.html) 1972-01-24
FR1561479A (cg-RX-API-DMAC10.html) 1969-03-28
DK115473B (da) 1969-10-13
DE1695124A1 (de) 1970-08-20
GB1222397A (en) 1971-02-10
US3652543A (en) 1972-03-28
IL29485A (en) 1971-07-28
NO124369B (cg-RX-API-DMAC10.html) 1972-04-10
FR1560654A (cg-RX-API-DMAC10.html) 1969-03-21
DE1668915A1 (de) 1972-03-09
NL6802257A (cg-RX-API-DMAC10.html) 1968-08-19
CH481110A (de) 1969-11-15

Similar Documents

Publication Publication Date Title
AU425114B2 (cg-RX-API-DMAC10.html)
FR1560654A (cg-RX-API-DMAC10.html)
AT298283B (cg-RX-API-DMAC10.html)
AU416737B2 (cg-RX-API-DMAC10.html)
AU2277767A (cg-RX-API-DMAC10.html)
AU342066A (cg-RX-API-DMAC10.html)
AU2528767A (cg-RX-API-DMAC10.html)
AU3189468A (cg-RX-API-DMAC10.html)
AU2116667A (cg-RX-API-DMAC10.html)
AU610966A (cg-RX-API-DMAC10.html)
AU2454867A (cg-RX-API-DMAC10.html)
AU3151267A (cg-RX-API-DMAC10.html)
BE711050A (cg-RX-API-DMAC10.html)
AU25066A (cg-RX-API-DMAC10.html)
BE711751A (cg-RX-API-DMAC10.html)
BE162295A (cg-RX-API-DMAC10.html)
AU1614766A (cg-RX-API-DMAC10.html)
BE692198A (cg-RX-API-DMAC10.html)
BE709120A (cg-RX-API-DMAC10.html)
BE710096A (cg-RX-API-DMAC10.html)
BE692922A (cg-RX-API-DMAC10.html)
BE692654A (cg-RX-API-DMAC10.html)
AU23366A (cg-RX-API-DMAC10.html)
AU1868267A (cg-RX-API-DMAC10.html)
BE704066A (cg-RX-API-DMAC10.html)